http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 481 reviews. 481 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Minirin

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Minirin uses and description

Sort by popularity
Minirin - Minirin is a synthetic replacement for vasopressin, the hormone that reduces urine production during sleep. It may be taken nasally, intravenously, or as a pill. Doctors prescribe Minirin most frequently for treatment of diabetes insipidus or bedwetting.

In December 2007, US drug regulators banned using Minirin nasal sprays for treating bedwetting, but said that Minirin pills are still a safe bedwetting treatment for otherwise healthy patients. The regulators reviewed the drug after two patients using Minirin nasal sprays died from hyponatremia, an imbalance of sodium levels in the body.

Central Diabetes Insipidus : The use of Minirin (dDAVP) in patients with an established diagnosis will result in a reduction in urinary output with concomitant increase in urine osmolality and decrease in plasma osmolality. This will result in decreased urinary frequency and decreased nocturia. Primary Nocturnal Enuresis: Minirin (dDAVP) tablets is indicated for the treatment of primary nocturnal enuresis in patients ≥5 years who have normal ability to concentrate urine. Nocturia: Symptomatic treatment of nocturia in adults associated with nocturnal polyuria ie, nocturnal urine production exceeding bladder capacity. Renal Concentrating Capacity Test: Minirin (dDAVP) nasal spray, intranasal solution and injection can be used to test the capacity of the kidneys to concentrate urine; as a diagnostic aid in the examination of the kidney function. This is especially useful in the differential diagnosis between level of urinary tract infections. Cystitis will, opposite to pyelonephritis, not cause a subnormal ability to concentrate urine. Hemophilia A and von Willebrand's Disease: Minirin (dDAVP) injection is indicated for the therapeutic control of bleeding and bleeding prophylaxis in connection with minor surgical procedures in patients with mild haemophilia A and von Willebrand's disease who respond positively to the test dose. In exceptional cases, even moderate forms of the disease can be treated. Minirin (dDAVP) must not be used in patients with von Willebrand's disease type IIB. Treatment of nocturia associated with nocturnal polyuria in adults.

Central Diabetes Insipidus : The use of Minirin (dDAVP) in patients with an established diagnosis will result in a reduction in urinary output with concomitant increase in urine osmolality and decrease in plasma osmolality. This will result in decreased urinary frequency and decreased nocturia. Primary Nocturnal Enuresis: Minirin (dDAVP) tablets and nasal spray are indicated for the treatment of primary nocturnal enuresis in patients ≥5 years. Symptomatic treatment of nocturia in adults associated with nocturnal polyuria ie, nocturnal urine production exceeding bladder capacity. Renal Concentrating Capacity Test: Minirin (dDAVP) nasal spray and injection can be used to test the capacity of the kidneys to concentrate urine; as a diagnostic aid in the examination of the kidney function. This is especially useful in the differential diagnosis between level of urinary tract infections. Cystitis will, opposite to pyelonephritis, not cause a subnormal ability to concentrate urine. Hemophilia A and von Willebrand's Disease: Minirin (dDAVP) injection is indicated for the therapeutic control of bleeding and bleeding prophylaxis in connection with minor surgical procedures in patients with mild haemophilia A and von Willebrand's disease who respond positively to the test dose. In exceptional cases, even moderate forms of the disease can be treated. Minirin (dDAVP) must not be used in patients with von Willebrand's disease type IIB.

Indications: diabetes insipidus, renal function tests, haemorrhagic disorders

Indications: diabetes insipidus, nocturnal enuresis, polyuria, polydipsia, haemorrhagic disorders

Cranial diabetes insipidus,Primary nocturnal enuresis,Type I Von Willebrand’s disease,Testing of fibrinolytic response,Diagnosis of diabetes insipidus,Renal function testing, Nocturia associated with multiple sclerosis.

Active ingredients: Desmopressin
Unit description, dosagePrice, USD
Injectable; Injection; Desmopressin Acetate 0.004 mg / ml
Spray, Metered-Dose; Nasal; Desmopressin Acetate 0.01 mg / dose
Tablet; Oral; Desmopressin Acetate 0.1 mg
Tablet; Oral; Desmopressin Acetate 0.2 mg
MINIRIN Capsule/ Tablet / 0.1mg (15 units)$ 5.56
MINIRIN Liquid / 250mcg (2.5ml units)$ 7.41
Minirin 0.1mg TAB / 15$ 7.19
Minirin 10mcg N-SPY / 2.5ml$ 7.41
Minirin 4mcg/ml INJ / 10x1ml
Minirin (dDAVP) 0.1 mg x 30's
Minirin (dDAVP) 0.2 mg x 30's
Minirin (dDAVP) 0.1 mg/1 mL x 2.5 mL
Minirin (dDAVP) 0.1 mg/1 mL x 5 mL
Minirin (dDAVP) 4 mcg/1 mL x 1 mL x 10's
Minirin 0.1 mg x 30's$ 61.60
Minirin 0.2 mg x 30's$ 123.15
0.1 mg x 15's$ 7.19
0.1 mg x 1 mL x 2.5ml$ 8.70
4 mcg x 1 mL x 10's
Minirin 0.1 mg x 1 loï 30 Tablet
Minirin (dDAVP) 0.2 mg x 15's
Minirin (dDAVP) 0.2 mg x 90's
Minirin (dDAVP) 60 mcg x 30's
Minirin (dDAVP) 120 mcg x 30's
Minirin 0.1mg x 1mL N-SPY / 2.5ml$ 8.70
Minirin 4mcg x 1mL INJ / 10

List of minirin brand and generic drugs

Esmon (Greece)
Minirin Melt (Thailand)
Powder; Oral; Desmopressin 0.06 mg
Powder; Oral; Desmopressin 0.12 mg
Powder; Oral; Desmopressin 0.24 mg
Minirin Melt 60 mcg x 30's
Minirin Melt 120 mcg x 30's
Minirin-Melt (Georgia, Turkey)
Minirin; DDAVP
Minirinmelt (Denmark, France)
Powder; Oral; Desmopressin 0.06 mg
Powder; Oral; Desmopressin 0.12 mg
Powder; Oral; Desmopressin 0.24 mg
Minrin (Luxembourg, Netherlands)
Minurin (Denmark, Spain)
Minurin Gotas (Spain)
Minurin Paranova (Denmark)
Minurin Singad Pharma (Denmark)
Minurin Sol Pulv Nasal (Spain)
Miram (Bulgaria)
Nafiset (Mexico)
Solution; Nasal; Desmopressin Acetate 8.9%
Noctissin (Bulgaria, Oman)
Nocturin (Germany, Luxembourg)
NOCTURIN Capsule/ Tablet / 5mg (10 units)$ 0.93
NOCTURIN Capsule/ Tablet / 2.5mg (10 units)$ 0.56
Nocturin 2.5mg TAB / 10$ 0.78
Nocturin 5mg TAB / 10$ 1.46
2.5 mg x 10's$ 0.78
5 mg x 10's$ 1.46
Nocturin 5 mg Tablet$ 0.15
Nocturin 2.5 mg Tablet$ 0.08
Nocutil (Austria, Denmark, Germany, Hungary, Sweden, Switzerland)
Spray; Nasal; Desmopressin Acetate 0.1 mg / ml
Tablet; Oral; Desmopressin Acetate 0.1 mg
Tablet; Oral; Desmopressin Acetate 0.2 mg
Nordurine (Ireland, Luxembourg)
Novo-Desmopressin (Canada)
Tablet; Oral; Desmopressin Acetate 0.1 mg
Tablet; Oral; Desmopressin Acetate 0.2 mg
Octim (France, United Kingdom)
Injectable; Injection; Desmopressin Acetate 15 mg / ml
Spray; Nasal; Desmopressin Acetate 150 mcg / dose
Octostim (Argentina, Australia, Austria, Bahrain, Belgium, Canada, Chile, China, Colombia, Denmark, Egypt, Estonia, Finland, Germany, Hong Kong, Hungary, Israel, Jordan, Kuwait, Latvia, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Norway, Qatar, Saudi Arabia, Spain, Sweden, Switzerland, Syria, Turkey, United Arab Emirates, Yemen)
Injectable; Injection; Desmopressin Acetate 15 mcg / ml
Injectable; Injection; Desmopressin Acetate 150 mcg / dose
Spray; Nasal; Desmopressin Acetate 1.5 mg / ml
Octostim 15 mcg/1 mL x 10's
PMS-Desmopressin (Canada)
Tablet; Oral; Desmopressin Acetate Trihydrate 0.1 mg
Tablet; Oral; Desmopressin Acetate Trihydrate 0.2 mg

Show all Minirin generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer